EUVIMEDEUVIMED entdecken
Open Access

Combining TMS and Ketamine for Treatment-Resistant Depression: Clinical Rationale, Current Evidence, and Practical Guidance

Ian A Cook

Focus · 2026-07 · 24 (3) · 326-330

DOI: 10.1176/appi.focus.20260014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Focus, 2026-07. Verfasst von Ian A Cook. Beteiligte Einrichtung: Los Angeles TMS Institute, Los Angeles. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Nonpharmacologic Somatic TreatmentdepressionketaminerTMS

Autor:innen und Institutionen

  • Los Angeles TMS Institute, Los Angeles.

Zitieren

APA

Cook, I. A. (2026). Combining TMS and Ketamine for Treatment-Resistant Depression: Clinical Rationale, Current Evidence, and Practical Guidance. Focus, 24(3), 326-330. https://doi.org/10.1176/appi.focus.20260014

Vancouver

Cook IA. Combining TMS and Ketamine for Treatment-Resistant Depression: Clinical Rationale, Current Evidence, and Practical Guidance. Focus. 2026;24(3):326-330. doi:10.1176/appi.focus.20260014

BibTeX
@article{Cook2026,
  author = {Cook, Ian A},
  title = {Combining TMS and Ketamine for Treatment-Resistant Depression: Clinical Rationale, Current Evidence, and Practical Guidance},
  journal = {Focus},
  year = {2026},
  volume = {24},
  number = {3},
  pages = {326--330},
  doi = {10.1176/appi.focus.20260014}
}
Kostenlos starten →